New board members were elected and retiring ones thanked at the recent annual general meetings of the West Island Palliative Care Residence and its Foundation. The meetings officially end the 2015-16 fiscal year for Canada’s largest freestanding palliative care facility, one marked again by very strong support from the West Island community.
Rhonda O’Gallagher, Vice President, Corporate Affairs of Pfizer Canada Inc., was elected the new President of the Foundation Board, succeeding Robert Havill, Director, Wealth Advisory, TURN8 Partners, who served the past two years and continues on the Foundation board as Past President but has retired from the Operations board. The new Vice-President is Janice Murray, CPA, CA, CFO, LACan Region Novartis Pharmaceuticals, Treasurer is Gilles Girouard, CPA, CMA, Planner – Administrative Office – Culture, Sports, Leisure and Community Development, City of Pointe-Claire and Richard Pattee is Secretary.
Val Pietrantonio, Vice President, Human Resources of Merck Canada Inc., remains as President of the Residence’s Operations Board after taking on the position a year ago. Operations First Vice President is Consulting Advisor, Commercial effectiveness in healthcare Allen Van der Wee and Second Vice President is Senior Advisor to the President, McKesson Canada, Dale Weil. Jean-Marc Brousseau, President, Laboxy Inc., is Treasurer and immigration-citizenship attorney Tony Manglaviti is Secretary.
Several retiring Directors were thanked at the meeting for their volunteer service to the Residence. In particular, Beverly Robb, President, Marshall Equipment Ltd., was thanked for her 14 years of service on both boards, including serving most recently as President of the Operations Board. After remaining as Past President for the last year she has now retired from both boards.
“Totally committed volunteers such as Bev Robb are crucial to our success, both financially as well as helping us deliver quality palliative care to our community,” said Teresa Dellar, Executive Director and Co- Founder. “Bev’s commitment to our success has been unwavering and we thank her and the other retiring directors for their great work and support. The expertise all our directors bring helps us immensely.”
Those leaving the Foundation Board are: Dale Weil, Jean-Marc Brousseau, Louise Trottier, Andrew Carter, Philippe Labelle and Brenda Rodricks.
New directors joining the Foundation Board are: James Hindley, CIB, President, Hindley Financial Services Inc.; Linda Ward O’Farrell, CHRL, SCERP, SCGMP, President, Ward O’Farrell Consultants Inc.; Ted Fletcher, President and CEO, Mint Green Group Inc.; and Greg Weil, Manager, The Martlet Foundation.
Other continuing Foundation directors are: Silvana D’Argenio, Financial Planner, RBC; Yolande James, Commentator, RDI and CBC; and Val Pietrantonio, Vice President, Human Resources, Merck Canada Inc.
New directors joining the Operations Board are: Dawn Graham Svoronos, retired pharmaceutical executive and board member for various life sciences companies; and Bernard Lapointe, MD, Eric M. Flanders Chair in Palliative Medicine, McGill University, and Chief, Palliative Care Division, Jewish General Hospital.
Other directors continuing on the Operations Board are: Michael Ankcorn, Consulting Advisor, Life Sciences; Gary Fabian, Gary G. Fabian Consulting Services; Phillip Gattola, CPA, CA, Chief Financial Officer, I-D Foods Corporation / Tantrum Corporation; France Remete, Lecturer, Faculty of Nursing,
Université de Montréal; and Rhonda O’Gallagher, Vice President, Corporate Affairs, Pfizer Canada Inc.
Russell Williams, Co-Founder of the Residence and Vice-President, Government Relations and Public Policy, Canadian Diabetes Association, is an Honourary Founding Member of the boards. Also on both boards are Teresa Dellar, MSW, PSW, FT and Lori Morris, CPA, CA.